(Q45118540)

9 December 2017

title

Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada (English)

1 reference

9 December 2017

0 references

0 references

Caro JJ

1

1 reference

9 December 2017

Getsios D

2

1 reference

9 December 2017

Caro I

3

1 reference

9 December 2017

Klittich WS

4

1 reference

9 December 2017

O'Brien JA

5

1 reference

9 December 2017

publication date

1 November 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

21

1 reference

9 December 2017

issue

11

1 reference

9 December 2017

page(s)

1229-1236

1 reference

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01330.X

Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01330.X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01330.X

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01330.X

Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01330.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01330.X

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01330.X

Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01330.X

Diabetes in Canada: direct medical costs of major macrovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01330.X

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01330.X

10.1111/J.1464-5491.2004.01330.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference